Viatris Inc
13 nominees · 3 ballot items.
Election of 13 director nominees; advisory vote to approve the 2024 compensation of Viatris' named executive officers (Say-on-Pay); and ratification of Deloitte & Touche LLP as Viatris' independent registered public accounting firm for 2025.
Follow how the vote landed and what changed on Viatris Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElection of 13 director nominees to hold office until the 2026 annual meeting, as recommended by the Board.
- 2
Advisory Vote to Approve the 2024 Compensation of the Named Executive Officers of the Company
ManagementBoard: FORNon-binding advisory vote on the 2024 compensation of Viatris' named executive officers, as disclosed in the proxy statement.
- 3
Ratification of the Selection of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025
ManagementBoard: FORRatification of Deloitte & Touche LLP as Viatris' independent registered public accounting firm for the 2025 fiscal year.
Nominees on the ballot13
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | DAVIS SELECTED ADVISERS | 6.7% | 78,211,191 | $1.1B |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 6.4% | 74,716,631 | $1.0B |
| 3 | PRICE T ROWE ASSOCIATES INC /MD/ | 5.5% | 64,134,134 | $866M |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.6% | 53,911,237 | $728M |
| 5 | STATE STREET CORP | 4.5% | 52,233,699 | $706M |
| 6 | BlackRock, Inc. | 3.2% | 37,173,067 | $502M |
| 7 | DIMENSIONAL FUND ADVISORS LP | 3.0% | 35,257,432 | $476M |
| 8 | Rubric Capital Management LP | 2.9% | 33,500,000 | $453M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 28,087,981 | $379M |
| 10 | BlackRock, Inc. | 2.1% | 24,665,335 | $333M |
Other Healthcare sector meetings6
Upcoming shareholder meetings at Viatris Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Viatris Inc 2025 annual meeting?
- Viatris Inc (VTRS) holds its 2025 annual shareholder meeting on Friday, December 5, 2025.
- What is the record date for the Viatris Inc 2025 meeting?
- The record date for the Viatris Inc 2025 meeting is Friday, October 10, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Viatris Inc's 2025 meeting?
- The board is presenting 13 director nominees at the Viatris Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Viatris Inc 2025 meeting?
- Shareholders will vote on 3 proposals at the Viatris Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.